Latest From OcuSciences Inc.
This Month's Profile Group, Skin Is In With Biomedical Investors, features profiles of Aclaris Therapeutics, Alexar Therapeutics, Rogne Bioscience, and Scioderm. Plus these Start-Ups Across Health Care: Harpoon Medical, OcuSciences, Oncoceutics, Pelvalon, and Procyrion.
OcuSciences Inc.'s OcuMet Beacon is a noninvasive and rapid diagnostic screening tool for retinal disease. The current ophthalmic standard of care, optical coherence tomography, evaluates structural change in retinal thickness or swelling after retinal damage has occurred, but OcuMet can provide a level of functional testing before damage occurs, which is especially important for latent diabetics or patients undiagnosed for retinal diseases.
- Diagnostic Imaging Equipment & Supplies
- Monitoring Equipment & Devices
- Therapeutic Areas
- Metabolic Disorders
- North America
- Parent & Subsidiaries
- OcuSciences Inc.
- Senior Management
- Victor M Elner, MD, PhD, Interim CEO & CMO
- Contact Info
Phone: (734) 395-9905
3744 Plaza Dr.
Ann Arbor, MI 48108
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.